Weight Loss Injection Prices and Klarna: What You're Actually Deciding

How UK private weight loss injection pricing actually works

Private pricing for medicines like Mounjaro (tirzepatide) and Wegovy (semaglutide) is set by each provider, and what the headline figure covers varies considerably. Some quote a per-pen price that excludes the consultation, the prescription, delivery and ongoing clinical support. Others bundle everything. Comparing two numbers side by side tells you very little if the contents of each quote are different.

For context on the market: Eli Lilly raised Mounjaro's UK list price from September 2025, with reported private prices ranging roughly £149 to £375 per four-week supply depending on the dose and the provider. Those figures are widely reported and hedged as approximations — actual prices shift, and lower doses cost less than maintenance doses. If you want a clearer picture of how dose affects cost over a typical treatment course, this breakdown covers the landscape in more detail. If you want a clearer picture of how dose affects cost over a typical treatment course, this breakdown of weight loss injection pricing covers the landscape in more detail.

Payment plans and Klarna-style options are sometimes offered by providers as a way to spread that monthly cost. Whether spread payments are available at any given service is a separate question from whether the underlying price is fair or complete. How Klarna works for weight loss injections goes into the mechanics of that specifically, including what to check before spreading payments across several months.

What tends to disappear from the cheaper quotes

A price that looks noticeably lower than others in the market often reflects what's been removed rather than a better deal. The things most commonly absent: a genuine clinical consultation (replaced by a brief questionnaire with no prescriber review), a real prescription issued by a named practitioner, same-day or next-day delivery, and any form of follow-up if something goes wrong or a dose review is needed.

For a prescription medicine (one that requires titration over months, that interacts with oral contraceptives at certain doses, and that carries a regulator-monitored side-effect profile) aftercare isn't a luxury add-on. The NHS sets out the importance of clinical oversight and lifestyle support alongside weight management medicines on its weight management injections guidance page, and that framing applies to private prescribing too.

The other thing worth noting: discount codes or promotional pricing attached to prescription medicines from sources you can't verify on a register are a specific red flag, not a bargain. The MHRA has warned repeatedly about counterfeit weight loss pens sold online. You can check whether any pharmacy supplying you holds a valid GPhC registration at the GPhC pharmacy register. Unverified sellers offering these medicines without a clinical assessment are the ones whose prices tend to look most attractive.

Where nume stands on price, and why

One misconception that comes up often: that a transparent, all-in price from a regulated pharmacy must mean you're overpaying for a brand name. That's not quite right. The price difference between providers usually reflects what's included, not a margin on the same clinical service.

At nume, one price covers the consultation, the prescription issued by a GPhC-registered prescriber, the medicine itself, free next-working-day tracked delivery, and seven-day aftercare. There's no subscription. There are no auto-renewals. There are no discount codes, because we don't run them. We're not positioned as the cheapest option in the market, deliberately, because the service wrapped around the medicine is what makes the supply safe and clinically appropriate. What the price on our treatment page buys you is all of that, in one figure, with nothing billed separately afterwards.

For a fuller look at how prices compare across different injection options, this page on weight loss injection prices covers each medicine side by side.

Why 'cheapest' is the wrong question for a prescription medicine

Price matters, there's no point pretending otherwise when a course of treatment runs across several months. But for a prescription-only medicine with a titration schedule, a monitoring requirement and a supply chain that's been subject to significant counterfeit enforcement, the cheapest listing answers the wrong question.

The right question is whether the supply is genuine, whether a clinician has assessed whether it's appropriate for you, and whether there's someone available to speak to if side effects appear or a dose change is needed. NICE's appraisal of tirzepatide, TA1026, sets out the clinical criteria under which this medicine is recommended, eligibility isn't just a BMI figure, and a proper assessment is what determines whether treatment is suitable in the first place.

If NHS access is something you're also weighing up, this comparison of NHS and private injection costs sets out both routes honestly. And if you've already done the research and want to speak to a prescriber directly, our free consultation is where to start. Speak to our prescribers about your circumstances and they'll tell you plainly whether treatment is appropriate, no charge, no commitment before that point.